
The policy is a drug-compounding framework, not a supplement pathway, but it changes the regulatory backdrop for peptide products, drug preclusion arguments, and gray-market competition.
The ingredient is isolated from baker’s yeast (Saccharomyces cerevisiae).
Norweigian ingredients supplier NutraQ (Norway;
The company describes NBG as a natural and patented bioactive compound that “is proven to induce correct and optimal immune response in animals and humans. The immune potentiating feature of NBG is well recognized, and the compound has thus been used as a health-promoting food supplement for more than 14 years in Norway and for more than 10 years in United States and in Japan.”






